Characterization and Preclinical Perspectives of Organic Small Molecule Drug Metabolites in Drug-drug Interactions

Publisher： Bentham Science Publishers

E-ISSN： 1875-5348|20|17|1827-1834

ISSN： 1385-2728

Source： Current Organic Chemistry, Vol.20, Iss.17, 2016-07, pp. : 1827-1834

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Small Molecule–small Molecule Interactions in Overcoming Biological Barriers for Antibacterial Drug Action

By Zloh Mire   Gibbons Simon  

Theoretical Chemistry Accounts, Vol. 117, Iss. 2, 2007-02 ,pp. : 231-238

Springer Publishing Company

Access to resources Recommend Favorite

Prediction of Drug-Drug Interactions with Bupropion and Its Metabolites as CYP2D6 Inhibitors Using a Physiologically-Based Pharmacokinetic Model

By Xue Caifu   Zhang Xunjie   Cai Weimin  

Pharmaceutics, Vol. 10, Iss. 1, 2017-12 ,pp. : 1-1

MDPI

Access to resources Recommend Favorite

Venetoclax (ABT-199) Might Act as a Perpetrator in Pharmacokinetic Drug–Drug Interactions

By Weiss Johanna   Gajek Thomas   Köhler Bruno Christian   Haefeli Walter Emil  

Pharmaceutics, Vol. 8, Iss. 1, 2016-02 ,pp. : 5-5

MDPI

Access to resources Recommend Favorite

Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs

By Klatt Sabine   Fromm Martin F.   König Jörg  

Pharmaceutics, Vol. 3, Iss. 4, 2011-10 ,pp. : 680-705

MDPI

Access to resources Recommend Favorite

Synthesis and Characterization of Metabolites and Potential Impurities of the Antiulcerative Drug Tenatoprazole

By Reddy Ganta Madhusudhan   Prasada Raju V.V. N. K. V.   Babu J. Moses   Praveen Ch.   Khunt Mayur   Mukkanti K.   Pratap Reddy Padi  

Synthetic Communications, Vol. 38, Iss. 11, 2008-01 ,pp. : 1725-1736

Taylor & Francis Ltd

Access to resources Recommend Favorite